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Beta-glucuronidase-negative, sorbitol-nonfermenting isolates of Shiga toxin-producing Escherichia coli O157
comprise part of a clone complex of related enterohemorrhagic E. coli isolates. High-resolution genotyping
shows that the O157 populations have diverged into two different lineages that appear to have different
ecologies. To identify genomic regions unique to the most common human-associated genotype, suppression
subtractive hybridization was used to identify DNA sequences present in two clinical strains representing the
human lineage I O157:H7 strains but absent from two bovine-derived lineage II strains. PCR assays were then
used to test for the presence of these regions in 10 lineage I strains and 20 lineage II strains. Twelve conserved
regions of genomic difference for lineage I (CRDI) were identified that were each present in at least seven of
the lineage I strains but absent in most of the lineage II strains tested. The boundaries of the lineage I
conserved regions were further delimited by PCR. Eleven of these CRDI were associated with E. coli Sakai
S-loops 14, 16, 69, 72, 78, 82, 83, 91 to 93, 153, and 286, and the final CRDI was located on the pO157 virulence
plasmid. Several potential virulence factors were identified within these regions, including a putative hemo-
lysin-activating protein, an iron transport system, and several possible regulatory genes. Cluster analysis based
on lineage I conserved regions showed that the presence/absence of these regions was congruent with the
inferred phylogeny of the strains.
Enterohemorrhagic Escherichia coli (EHEC) serotype
O157:H7 is a major cause of both large-scale epidemics and
sporadic cases of diarrhea, hemorrhagic colitis, and hemolytic
uremic syndrome in many countries around the world (13, 34,
36, 54, 56). The annual incidence of reported E. coli O157:H7
infections in Canada and the United States ranges from 1.7 to
5.3 per 100,000 persons and may be much higher in certain
regions (14, 56). Within the United States alone, it has been
estimated that approximately 73,000 cases of E. coli O157:H7
infection occur annually (33). The most common E. coli
O157:H7 isolates are motile, non-sorbitol fermenting (SOR),
and -glucuronidase negative (GUD), while a nonmotile
SOR GUD O157:H clone has also been isolated in Ger-
many (20) and a nonmotile SOR GUD O157:H clone is
commonly isolated in Australia (46).
Population genetic analysis has shown that E. coli O157:H7
and O157:H isolates belong to a geographically disseminated
clone complex that acquired virulence genes independently
from other EHEC isolates (31, 45, 61, 62). Despite the clonal
nature of E. coli O157:H7 and O157:H isolates, significant
variability was observed when they were tested by high-resolu-
tion genomic typing methods, such as pulsed field gel electro-
phoresis and octamer-based genome scanning (OBGS) (12,
22, 23, 53), implying that subpopulations are diverging quite
rapidly.
OBGS is a large-scale genome comparison method based on
pattern analysis of PCR amplification products generated us-
ing overrepresented octamers as primers. Recent studies using
OBGS suggest that extant populations of O157:H7 isolates
have diverged through two primary lineages, lineage I and
lineage II, and that these lineages can be detected in geograph-
ically unlinked regions, such as the United States and Australia
(22, 23). The origin of these two lineages, therefore, appears to
predate the geographical spread of E. coli O157:H7 and the
regional evolution of the SOR GUD O157:H clone com-
monly isolated in Australia (23). More recently, the lineage-
specific polymorphism assay (LSPA-6) was developed, based
on six loci that show bias in their allelic distribution between
the two lineages. The LSPA-6 is therefore a more efficient
alternative for inferring lineage assignments compared to la-
borious OBGS typing (63). The two methods were demon-
strated to generate highly concordant data (63). All lineage I
isolates were LSPA-6 genotype 111111 (lineage I allele at each
locus), while the majority of lineage II isolates were LSPA-6
genotypes 222222, 211111, and 212111.
In the initial OBGS studies and in the LSPA-6 study, a low
proportion of human strains were observed in OBGS lineage II
and LSPA-6 genotype 222222, respectively (22, 63). The pau-
city of OBGS lineage II and LSPA-6 genotype 222222 human
isolates led workers to postulate that these E. coli O157:H7
isolates may be deficient in their abilities either to be trans-
mitted to humans or to cause clinically significant human in-
fections (22, 63). Several other studies also suggest that there
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are clear differences in the expression of virulence attributes,
such as Shiga toxin and the locus for enterocyte effacement
(LEE) proteins, by E. coli O157:H7 isolates from humans and
from cattle (27, 32, 47, 48). These latter studies, however, did
not consider the population structure of E. coli O157:H7 (e.g.,
lineage of descent) as a variable.
In this study, suppression subtractive hybridization (SSH)
was used to identify genomic regions present in E. coli
O157:H7 lineage I (LSPA-6 111111) strains but absent from
lineage II (LSPA-6 222222) strains. We show that lineage I
strains do indeed share a set of unique genes that are largely
absent in lineage II strains. Several of these genes encode
proteins that could contribute to virulence characteristics or
which are known to regulate expression of virulence genes.
MATERIALS AND METHODS
Bacterial strains. The bacterial strains included in this study are listed in Table
1. OBGS type strains 93-001, FDA 516-520, and FRIK 523-2001 have previously
been described by Kim et al. (22). ZAP strains were obtained from David Gally
at the University of Edinburgh (32). Escherichia coli O157:H7 strains EDL933
(ATCC 700927) and Sakai (ATCC BAA-460) were obtained from American
Type Culture Collection (Manassas, VA). The remaining strains were from our
culture collection and were isolated from humans or cattle in Canada. LSPA-6
genotyping of these strains was performed as described previously (63).
Preparation of suppression subtractive hybridization DNA libraries. Bacteria
were grown overnight in brain heart infusion broth (Difco, Becton Dickinson
Microbiology Systems, Sparks, MD) in a 37°C shaker-incubator (200 rpm), and
genomic DNA was extracted from harvested cells using the DNeasy tissue kit
(QIAGEN, Valencia, CA).
SSH was performed using the Clontech PCR-Select bacterial genome subtrac-
tion kit (BD Biosciences, Palo Alto, CA). Advantage polymerase mix (BD Bio-
sciences) was used during amplification steps. Two SSH experiments were per-
formed, the lineage I strain (LSPA-6 genotype 111111) E. coli O157:H7 Sakai
was subtracted with the bovine-derived lineage II strain FRIK920 (LSPA-6
genotype 222222), and a second human-derived lineage I strain 93-001 (LSPA-6
genotype 111111) was subtracted with bovine-derived lineage II strain
EC19970520 (LSPA-6 genotype 222222). In addition to the RsaI-digested DNA
recommended in the Clontech kit, each SSH experiment was also performed on
AluI- and HaeIII-digested DNA to increase the diversity of DNA fragments
obtained. The SSH DNA fragments isolated in these experiments were cloned
into the pCR2.1-TOPO plasmid vector, using the TOPO TA cloning kit (Invitro-
gen, Carlsbad, CA), and plated on LB agar (Difco) containing 50 g/ml of
ampicillin or kanamycin (Sigma-Aldrich Canada, Oakville, ON, Canada).
Sequence analysis of suppression subtractive hybridization DNA libraries.
Cloned DNA inserts were amplified by PCR using the primers M13 Forward,
5-GTAAAACGACGGCCAG-3, and M13 Reverse, 5-CAGGAAACAGCTA
TGAC-3 (Invitrogen). The amplified DNA was purified by passage through
superfine Sephadex G-50 (Sigma) packed into a multiscreen 96-well filtration
plate (Millipore, Billerica, MA). Sequencing was performed using M13 Forward
and M13 Reverse primers with the DYEnamic ET terminator cycle sequencing
kit (GE Healthcare, Piscataway, NJ), and sequencing products were purified by
passage through superfine Sephadex G-50 plates as before. Sequence analysis
was performed on a MegaBACE 500 capillary sequencer (GE Healthcare).
Base calling of sequence trace data was performed using the PHRED algo-
rithm as implemented in the Interphace program (CodonCode Corporation,
Dedham, MA). Base-called sequences from both SSH DNA libraries were
pooled and analyzed with the SeqMan 5.05 sequence analysis program (DNAStar
Inc., Madison, WI). This program removed vector and adaptor sequences and
grouped sequences displaying at least 90% sequence homology into “contigs.”
BlastN (1) searches were then performed on contig consensus sequences using
the National Center for Biotechnology Information (http://www.ncbi.nlm.nih
.gov/) and The Institute for Genomic Research (http://www.tigr.org/) BLASTN
servers. Sequences that displayed at least 90% sequence identity to published
chromosomal and plasmid DNA sequences of the lineage I E. coli O157:H7
Sakai strain (16, 29) were included in the final analysis. Genomic regions within
the E. coli Sakai chromosome and plasmids that contained localized clusters of
ORFs represented in the SSH libraries at high frequency were identified. The
representation of these regions was significantly higher than the background
TABLE 1. Escherichia coli O157:H7 strains included in the study
Strain LSPA-6 genotype Source Country of origin Phage type Reference(s)
93-001 111111 Human United States 14 22, 23
EC19950361 111111 Bovine Canada 87
EC20000122 111111 Bovine Canada 31
ECI-577 111111 Bovine Canada 4
EDL933 111111 Human United States 21 43
FDA 516 111111 Human United States 21 22, 23
FDA 518 111111 Human United States 21 22, 23
FDA 520 111111 Human United States 1 22, 23
FRIK 523 111111 Human United States 34 22, 23
Sakai 111111 Human Japan 32 16
EC19920027 222222 Bovine Canada 34
EC19920283 222222 Human Canada 23
EC19970520 222222 Bovine Canada 67
ECI-1433 222222 Bovine Canada 23
ECI-633 222222 Bovine Canada 23
ER6554 222222 Human Canada 23
FRIK 1990 222222 Bovine United States 54 22, 23
FRIK 1999 222222 Bovine United States 23 22, 23
FRIK 920 222222 Bovine United States 23 22, 23
EC20011139 222222 Bovine Canada 82
ECI-882 211111 Human Canada 1
278F1 211111 Human Canada 2 21
Zap0032 211111 Bovine Scotland 8 32, 47, 48
Zap0054 211111 Bovine Scotland 32 32, 47, 48
Zap0058 211111 Human Scotland 87 32, 47, 48
ECI-241 222212 Human Canada 74
ER4511 222212 Human Canada 74
ECI-240 222213 Human Canada 54
FRIK 2001 222213 Bovine United States 54 22, 23
FRIK 1985 222223 Bovine United States 45 22, 23
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frequency across the chromosomal and plasmid sequences, although the fre-
quency at which individual ORFs within these regions were identified varied
from 1 to 24 times.
PCR screening. PCR assays were used to determine the distribution of these
highly represented genome regions within E. coli O157:H7 strains of different
LSPA-6 genotypes. Primers for these assays were designed to detect unique
DNA sequences from ORFs within each region (see Table S1 in the supplemen-
tal material). All primer sequences were queried by BLASTN to ensure that they
would not amplify multiple sequences within the E. coli Sakai genome. PCR
screening reactions were performed against genomic DNA isolated from 10
LSPA-6 genotype 111111 E. coli O157:H7 strains, 10 LSPA-6 genotype 222222
strains, and 10 strains of other LSPA-6 genotypes. This strain collection is
representative of the diversity within E. coli O157:H7 populations but is not
representative of the proportions of LSPA-6 genotypes that naturally occur in
humans and cattle. Larger numbers of LSPA-6 111111 and 222222 strains were
included, as these genotypes were previously reported to display a biased distri-
bution between human and bovine strains (63), and the proportions of human
and bovine strains within each major genotype are different than previously
described (63). Genome regions that were observed in these initial PCR screen-
ing reactions to be conserved in most or all LSPA-6 genotype 111111 strains but
rare or absent in LSPA-6 genotype 222222 strains were tested by additional PCR
assays against this same strain collection to identify the boundaries of the lineage
I-specific regions.
All PCR assays were performed in duplicate in a 20-l reaction volume
containing 1 buffer II (Applied Biosystems, Foster City, CA), 1.5 mM MgCl2,
0.2 mM each deoxynucleoside triphosphates, 1 U AmpliTaq DNA polymerase
(Applied Biosystems), 0.2 M primers, and 0.5 ng genomic DNA template. All
PCRs included an initial 2-min denaturation step at 94°C, followed by 30 cycles
of 1-min denaturation at 94°C, 1-min annealing, and 1-min extension at 72°C,
and a final 10-min extension at 72°C. Each PCR was tested against genomic DNA
of E. coli O157:H7 Sakai strain as a positive control, E. coli K12 MC1061 as a
negative control, and a no-template blank.
Cluster analysis of the distribution of lineage I-specific regions in E. coli
O157:H7 strains by UPGMA. Results of the preliminary PCR screening assays
were converted into binary data to indicate the presence or absence of a single
PCR marker for each of the different lineage I conserved regions within the
strains tested. A distance matrix of the binary data was created in PAUP version
4.0b10, and the distance matrix was imported into MEGA 3.1 (26) to generate an
unweighted-pair group method using average linkages (UPGMA) dendrogram.
RESULTS AND DISCUSSION
Analysis of SSH-derived sequences. Our experimental ap-
proach was to first identify candidate genomic regions that are
present in lineage I strains but absent in lineage II strains.
Candidate regions were identified using SSH from represen-
tative strains, and the candidate regions were then distin-
guished as strain specific versus lineage specific based on their
conservation across a larger, representative strain set. To this
end, two SSH experiments were conducted. In one library, the
lineage I strain (LSPA-6 genotype 111111) E. coli O157:H7
Sakai was subtracted with the bovine-derived lineage II strain
FRIK920 (LSPA-6 genotype 222222), and the second library
used a human-derived lineage I strain 93-001 (LSPA-6 geno-
type 111111) subtracted with bovine-derived lineage II strain
EC19970520 (LSPA-6 genotype 222222). A total of 1,155
clones prepared from SSH DNA libraries of RsaI-, AluI-, and
HaeIII-digested DNA were sequenced. Sequences were as-
sembled into 754 contigs, with each sequence possessing 90%
or greater sequence identity to other contributing sequences in
the same contig. BlastN search results of the contig consensus
sequences revealed that 85.1% of the contigs possessed se-
quences with greater than 90% sequence identity to one or
more of the ORFs present in the lineage I representative strain
E. coli O157:H7 Sakai chromosome or pO157 and pOSAK1
plasmid sequences (16, 29). This was expected, since E. coli
Sakai was used as the tester for preparing one of the SSH DNA
libraries. The frequency at which sequences possessing 90% or
greater sequence identity to each E. coli Sakai chromosomal
ORF was identified, either partly or wholly, within the SSH
libraries was enumerated, and 24 putative regions of genomic
difference for lineage I (RDI) identified on the E. coli Sakai
chromosome and pO157 and pOSAK1 plasmids were selected
for further testing (Fig. 1). These regions consisted of clusters
of 1 to 47 ORFs that were each identified in the SSH libraries
from 1 to 24 times. The locations of SSH sequences within
pO157 and pOSAK1 plasmids are not shown, but plasmid
ORFs with 90% or greater sequence identity to SSH library
sequences were evenly distributed across pOSAK1 (GenBank
accession number NC_002127) and concentrated in the region
of a putative reverse transcriptase within pO157 (GenBank
accession number AB011549).
Identification of lineage I conserved regions. Having iden-
tified candidate regions of the genome that are unique to
lineage I strains, the next step was to identify which of the
candidate RDI were conserved across multiple lineage I strains
and likewise absent in multiple lineage II strains. While SSH is
a versatile tool for identification of sequence differences be-
tween bacterial strains, the time required to obtain and analyze
the subtracted sequences is substantial, thus limiting the num-
ber of strains that can be analyzed. To confirm the lineage-
specific distribution of the RDI, 30 different E. coli O157:H7
strains were subsequently tested for the presence of the RDI by
PCR. This confirmatory strain set comprised 10 lineage I
FIG. 1. Frequency of detection of sequences homologous to Escherichia coli Sakai (GenBank accession no. BA000007) ORFs within SSH
libraries.
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strains of LSPA-6 genotype 111111, 10 lineage II strains of
LSPA-6 genotype 222222 strains, and 10 lineage II strains
having other LSPA-6 genotypes. Each PCR-based RDI detec-
tion assay was performed using a single PCR assay designed to
detect DNA sequences within the 24 RDI. Twelve of the 24
RDI were conserved in at least seven of the LSPA-6 genotype
111111 strains but were found in two or fewer of the genotype
222222 strains (Table 2). Amplicons for each PCR assay cor-
responded in size to that predicted for E. coli Sakai. These
conserved RDI (CRDI) were also absent from other LSPA-6
genotypes, except for genotype 211111 strains. Their presence
within LSPA-6 genotype 211111 strains was variable.
To determine if the lineage-conserved distribution of these
regions was maintained when tested over a larger population
of E. coli O157:H7 strains, the representative PCR assay from
each CRDI (except CRDI 78) was tested against a larger set of
119 E. coli O157:H7 isolates of different LSPA-6 genotypes.
Sequences recognized by these assays were present in 81 to
100% of LSPA-6 genotype 111111 strains but were found in
7% of LSPA-6 genotype 222222 strains, confirming the ear-
lier screening results for these regions. Complete PCR assay
results for the preliminary screening of 30 strains for the pres-
ence of the 24 RDI regions and the subsequent testing of 119
strains for the presence of the 12 CRDI regions are shown in
Tables S2 and S3, respectively, of the supplemental material.
Localization of genomic boundaries of CRDI. While the SSH
and PCR screening results suggest 12 CRDI exist across the E.
coli Sakai chromosome and pO157 plasmid, it was not known
if the E. coli Sakai ORFs identified by SSH accurately reflected
the boundaries of these CRDI as they exist in lineage I strains.
Subsequent PCR screening assays were performed to confirm
the boundaries of the CRDI by testing for the presence of E.
coli Sakai DNA segments flanking the CRDI among lineage II
strains (Table 3) (16, 29). All but one of the estimated full-
length CRDI were localized within E. coli Sakai S-loops and
the corresponding E. coli EDL933 O-islands. These E. coli
O157:H7 chromosomal regions are absent from E. coli K-12
and are thought to have arisen by horizontal gene transfer (16).
The remaining CRDI was located on the pO157 virulence
plasmid of E. coli O157:H7 (7, 29). Complete PCR results for
these assays are shown in Table S2 of the supplemental mate-
rial. Amplicons from each of these additional PCR assays cor-
responded in size to that predicted for E. coli Sakai.
Relationships between CRDI and inferred phylogeny of dif-
ferent Escherichia coli O157:H7 LSPA-6 genotypes. To test for
congruence between presence/absence of CRDI and phylogeny
of the strains, cluster analysis was performed on the different
strains using a distance matrix developed from comparison of
the presence/absence of the CRDI. The LSPA-6 genotype was
then superimposed onto the corresponding neighbor-joining
dendrogram (Fig. 2). Strains of LSPA-6 genotypes 111111 and
222222 clustered separately on the basis of the CRDI identified
in this study. This would be expected based on the definition of
the CRDI, which were selected on the basis of their presence
in LSPA-6 111111 strains but not in LSPA-6 222222 strains.
LSPA-6 genotype 211111 strains, however, clustered with both
of the major groups, a result that is consistent with their vari-
able CRDI content. This variability suggests that the folD2
allele (the only lineage II allele in the 211111 genotype) may
have arisen independently in different genomic backgrounds or
that the CRDI identified in this study emerged differentially in
descendants of the original LSPA-6 211111 strains. Given that
the folD2 allele is thought to be the result of a tandem dupli-
cation event (23), it seems more plausible that that it is a
TABLE 2. Results of preliminary screening of ORF clusters identified in SSH libraries
RDI
ORF(s) represented in
SSH libraries
ORF(s) targeted
by primers
No. positive for LSPA-6 genotype Genotype
111111
conserved?
111111
(n  10)
222222
(n  10)
211111
(n  5)
Other
(n  5)
14 ECs0237–ECs0241 ECs0238 and -9 10 0 5 0 Yes
16 ECs0275–ECs0284 ECS0281 10 0 5 0 Yes
27 ECs0377–ECs0379 ECs0377 10 10 5 5 No
52 ECs0759–ECs0760 ECs0760 10 9 5 5 No
67 ECs1114–ECs1121 ECs1120 10 10 5 5 No
69a ECs1158–ECs1173 ECs1164 8 0 3 0 Yes
69b ECs1186–ECs1195 ECs1191 7 0 0 0 Yes
69c ECs1205–ECs1251 ECs1223 10 2 3 0 Yes
72 ECs1377–ECs1393 ECS1382 10 0 4 0 Yes
B1 ECs1425 ECs1425 10 10 5 5 No
78 ECs1576–ECs1600 ECs1588 and -9 8 0 0 0 Yes
82/83 ECs1687–ECs1705 ECs1698 10 0 3 0 Yes
91/92/93 ECs1929–ECs1958 ECs1954 10 0 0 0 Yes
B2 ECs1997–ECs1998 ECs1998 10 10 5 5 No
126/127 ECs2775–ECs2776 ECs2775 10 10 5 5 No
153 ECs2976–ECs2981 ECs2979 10 0 2 0 Yes
274a ECs4942–ECs4946 ECs4943 3 5 0 3 No
274b ECs4957–ECs4960 ECs4960 1 4 0 2 No
274c ECs4998–ECs5005 ECs5000 10 9 5 5 No
286 ECs5242–ECs5252 ECs5250 9 0 4 0 Yes
pO157-RTa pO157, sopB-RT (p36) Upstream of RT 9 0 0 0 Yes
pO157-katP pO157, katP katP 9 10 5 5 No
pO157-etpF pO157, etpF etpF 10 10 5 5 No
pOSAK1 pOSAK1 Unknown 5 0 1 0 No
a RT, putative reverse transcriptase.
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TABLE 3. Results of PCR screening to determine boundaries of CRDI in E. coli O157:H7 strains
CRDI ORF(s) targeted by primers
No. positive for LSPA-6 genotype
LSPA-6 genotype
111111 conserved?111111
(n  10)
222222
(n  10)
211111
(n  5)
Other
(n  5)
14 ECs0234 and -5 10 10 5 5 No
ECs0238 and -9 10 0 5 0 Yes
ECs0240 10 0 5 0 Yes
ECs0243 and -4 10 10 5 5 No
16 ECs0270 10 10 5 5 No
ECs0271 and -2 10 0 5 0 Yes
ECs0276 10 0 3 0 Yes
ECS0281 10 0 5 0 Yes
ECs0282 and -3 10 10 5 5 No
ECs0284 10 10 5 5 No
69a ECs1158 10 10 5 5 No
ECs1162 and -3 10 0 0 0 Yes
ECs1164 8 0 3 0 Yes
ECs1165 9 0 3 0 Yes
ECs1168 10 1 1 0 Yes
69b ECs1180 and -2 3 10 3 4 No
ECs1186 and -8 3 0 0 0 No
ECs1191 7 0 0 0 Yes
ECs1192 and -4 10 9 3 3 No
69c ECs1217 and -8 10 10 5 5 No
ECs1219 10 2 3 0 Yes
ECs1223 10 2 3 0 Yes
ECs1251 10 0 0 0 Yes
ECs1252 10 10 5 5 No
72 ECs1374 and -6 10 5 0 5 No
ECs1377 10 0 3 0 Yes
ECS1382 10 0 4 0 Yes
ECs1389 and -90 10 0 5 0 Yes
ECs1394 and -5 10 10 5 5 No
78 ECs1573 and -4 8 10 5 5 No
ECs1575 and -6 8 10 5 5 No
ECs1582 and -3 8 3 1 0 Yes
ECs1584 8 0 1 1 Yes
ECs1588 and -9 8 0 0 0 Yes
ECs1590 8 0 1 1 Yes
ECs1595 8 0 1 1 Yes
ECs1598 8 0 1 1 Yes
ECs1599 and -1600 8 0 0 0 Yes
82/83 ECs1687 10 10 5 5 No
ECs1691 10 0 4 0 Yes
ECs1698 10 0 3 0 Yes
ECs1705 10 0 4 0 Yes
ECs1706 10 10 4 5 No
ECs1707 9 9 4 5 No
91/92/93 ECs1927 10 10 5 5 No
ECs1931 and -2 10 0 0 0 Yes
ECs1937 to -40 10 0 0 0 Yes
ECs1945 10 2 0 1 No
ECs1953 10 0 0 0 Yes
ECs1954 10 0 0 0 Yes
ECs1957 10 0 0 0 Yes
153 ECs2979 10 0 2 0 Yes
286 ECs5240 and -1 7 10 5 5 No
ECs5242 9 0 5 0 Yes
ECs5250 9 0 4 0 Yes
ECs5252 9 0 5 0 Yes
ECs5253 10 10 5 5 No
ECs5254 to -6 10 10 5 5 No
PO157-RT pO157, sopB 9 10 5 5 No
pO157, upstream of reverse
transcriptase
9 0 0 0 Yes
pO157, reverse transcriptase 9 0 0 0 Yes
pO157, p36 9 10 5 5 No
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polyphyletic allele that arose from a simple mutation or lateral
transfer event as opposed to the hypothesis that multiple
events resulted in differential CRDI distribution within isolates
of this genotype. Strains from the remainder of the lineage II
LSPA-6 genotypes had profiles that were very similar to geno-
type 222222 strains.
Functional categorization of genes within CRDI. The results
of the PCR assays indicated that the CRDI were strongly
associated with LSPA-6 111111 strains and rare or absent in
LSPA-6 222222 strains. Because the LSPA-6 genotypes 111111
and 222222 show statistically significant biases in their distri-
bution among strains isolated from human clinical samples and
bovine fecal samples (63), it is possible that genes within the
CRDI could contribute to the apparently different ecological
distributions of the LSPA-6 genotypes that have been ob-
served. To identify genes within CRDI that could contribute to
host specificity, we conducted functional classification of the
ORFs present within the CRDI, based on annotation entries,
identification of homologous DNA sequences by BLASTN
searches, and Pfam identification (4) of common protein do-
mains and families using hidden Markov models (http://www
.sanger.ac.uk/Software/Pfam/). The results from this set of ex-
periments are summarized in Table 4.
The most striking characteristic of the ORFs contained
within the CRDI is their location with respect to mobile genetic
elements in E. coli Sakai (16). Nine of the 12 CRDI were within
Sp1, Sp5 (stx2), Sp7, Sp10, and Sp15 prophage and SpLE1 and
SpLE5 prophage-like elements (Table 4). One of the CRDI
was surrounded by Rhs element genes, mobile genetic ele-
ments that were originally identified based on their association
with recA-dependent intrachromosomal recombination (2, 10,
28). Five of the CRDI contained or were located in close
proximity to transposase genes. One CRDI was found on the
pO157 virulence plasmid (7, 29). Not surprisingly, a large pro-
portion of the ORFs identified within the CRDI were bacte-
riophage structural and regulatory genes, Rhs genes, and trans-
posases. These elements would be expected to promote
genomic recombination and rearrangement and may contrib-
ute to bacterial virulence through associated structural and
regulatory functions (58, 59).
Lineage I-specific CRDI 69 and 153 are located within E.
coli Sakai Sp5 and Sp15 prophages, respectively (Table 4).
These two prophages contain the structural genes for Stx2 and
Stx1, respectively. The Sp5 prophage has been shown to be
highly variable in both its genomic structure and integration
sites (37, 38, 51). The presence of the stx2 gene is strongly
FIG. 2. UPGMA dendrogram displaying relationship between LSPA-6 genotype and the presence of CRDI in Escherichia coli O157:H7
strains.
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associated with virulence in E. coli O157:H7 (5, 16, 24, 41). In
a recent study, it was reported that the Q antiterminator gene,
which regulates toxin gene expression in stx2 prophage, differs
between E. coli O157:H7 strains of different OBGS lineages
and that these differences are related to toxin production (27).
However, the Q antiterminator gene was not among the ORFs
identified within the SSH libraries in this study. Only a small
region located upstream of the stx1 and Q antiterminator genes
in the Stx1-converting Sp15 prophage was identified in the SSH
libraries. PCR assays confirmed that at least one of these
ORFs, ECs2979, was conserved in lineage I strains and absent
in lineage II strains.
A cluster of lineage I-specific ORFs within CRDI 82/83 may
represent an iron uptake system. Virulence genes, such as E.
coli O157:H7 stx1 genes (8), are often iron regulated. The
ORFs ECs1693 to ECs1697 are highly homologous to the
prrA-modD-yc73-fepC gene cluster located on the pyelonephri-
tis and cystitis pathogenicity island of uropathogenic E. coli
CFT073 (15). This gene cluster was proposed to be involved in
iron uptake in E. coli CFT073 (64). The fepC gene was re-
ported to be present in O157 EHEC isolates and absent from
non-O157 isolates, although the OBGS lineage of the O157
EHEC strains tested in this study was not examined (40). This
gene is also found in EAEC2 and DAEC2 phylogenetic groups
of enteroaggregative E. coli (EAEC) and diffusely adherent E.
coli (DAEC), respectively, and it has been proposed that these
groups might represent hypervirulent isolates of EAEC and
DAEC (40). Immediately following the prrA-modD-yc73-fepC
gene cluster are ECs1698, which is homologous to the Fe(III)
dicitrate transport system permease FecD protein of E. coli
CFT073 (60), and ECs1699, which is homologous to a putative
ATP-binding protein of the ABC transporter in Shigella flexneri
2a strain 301(18).
The ORF ECs1382 within CRDI 72 has 34% amino acid
similarity at its amino terminus to the gene for the hemolysin
activation protein HecB of Neisseria meningitidis (57), which
directs the translocation of hemolysin A (HlyA) across cyto-
plasmic and cell membranes (25), and it possesses two copies
of a 20-residue repeat found in the Bordetella pertussis filamen-
tous hemagglutinin family of adhesins (49). These homologies
suggest that ECs1382 might contribute to virulence. In a recent
investigation of the distribution of Z1640 (the E. coli EDL933
homologue of ECs1382) within different E. coli serotypes, in-
tact ECs1382/Z1640 was associated with serotypes that cause
hemolytic uremic syndrome and outbreaks of human illness,
while fragmented ECs1382/Z1640 was found in nonepidemic
human disease-associated strains of serotypes O91:H21 and
O113:H21 and animal-associated Shiga toxin-producing E. coli
serotypes not associated with human disease (52).
A number of ORFs were identified within the SSH libraries
that displayed homology to regulatory genes. These genes
could affect virulence of E. coli O157:H7 by regulating expres-
sion of effector genes directly involved in pathogenesis. The
genome sequence of E. coli O157:H7 Sakai contains five genes
homologous to the plasmid-encoded LEE regulatory protein
PerC, which is produced by certain enteropathogenic E. coli
(EPEC) strains (16, 17, 39, 44). Two of these perC homologue
(pch) genes, ECs1388 of CRDI 72 and ECs1588 of CRDI 78,
encode putative proteins with 25% and 39% sequence identity,
respectively, to EPEC PerC. ECs1388 and ECs1588 were iden-
tified within the SSH libraries and confirmed by PCR to be
present in lineage I strains and absent from lineage II strains.
TABLE 4. Summary of potential virulence factors contained within CRDI in E. coli O157:H7 strains
CRDI Genetic environment Potential virulence factor(s) identified within LSPA-6 genotype 111111 CR
14 Rhs elements None identified
16 Sp1 prophage None identified
69a Sp5 prophage ECs1170, gene for putative protein with DksA/TraR C4-type zinc finger domain (42)
69b Sp5 prophage None identified
69c Sp5 prophage, transposon ECs1236, gene for putative outer membrane precursor protein with Ail/Lom protein
domain (3, 35); ECs1250, gene for putative protein with DksA/TraR C4 type zinc
finger domain (42)
72 SpLE1 prophage-like element,
transposon
ECs1382, similar to hemolysin-activating protein hecB gene of Neisseria meningitidis
(57); ECs1386, similar to immunoglobulin-binding regulator ibrA gene of E. coli
ECOR-9 (50); ECs1387, similar to immunoglobulin-binding regulator ibrB gene of
E. coli ECOR-9 (50); ECs1388, similar to plasmid-encoded regulator perC gene of
EPEC (11); ECs1391, similar to bundle-forming pilus bfpM gene of EPEC EAF
plasmid (55)
78 Sp7 prophage ECs1588, similar to plasmid-encoded regulator perC gene of EPEC (11)
82/83 Transposon ECs1693, homologue of prrA of a proposed iron transport system in E. coli CFT073
(15); ECs1694, homologue of the modD of a proposed iron transport system in E.
coli CFT073 (15); ECs1695, homologue of yc73 of proposed iron transport system
in E. coli CFT073 (15); ECs1696, homologue of yc73 of proposed iron transport
system in E. coli CFT073 (15); ECs1697, homologue of fepC of proposed iron
transport system in E. coli CFT073 (15); ECs1698, homologue of iron transport
permease FecD of E. coli CFT073 (60); ECs1699, homologue of putative ATP-
binding protein of ABC transporter in Shigella flexneri 2a strain 301 (18)
91/92/93 Sp10 prophage, transposon None identified
153 Sp15 prophage None identified
286 SpLE5 prophage-like element,
transposon
ECs5250, required for colonization of calves (9); ECs5252, similar to BamHI control
element in Bacillus amyloliquefaciens (6)
pO157-RT a pO157 plasmid None identified
a RT, putative reverse transcriptase.
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While other pch genes have been demonstrated to modulate
expression of LEE transcription units in E. coli O157:H7 (17),
deletion or overexpression of ECs1388 or ECs1588 has not,
and their function, if any, in gene regulation remains to be
determined (44).
Other potential regulatory genes identified within the SSH
libraries include ECs1386 and ECs1387 of CRDI 72, which
display 80 and 85% identity to immunoglobulin-binding regu-
lator genes ibrA and ibrB of E. coli ECOR-9. These genes
regulate production of Escherichia coli immunoglobulin-bind-
ing (eib) genes in this strain (50). The ORF ECs5252 of CRDI
286 encodes a putative transcriptional regulator with homology
to the BamHI control element of Bacillus amyloliquefaciens
(6). Finally, the ORFs ECs1170 of CRDI 69a and ECs1250 of
CRDI 69c encode putative proteins with a pfam01258:Zn-
dskA_traR domain (30). The dskA gene of E. coli regulates
rRNA transcription (19, 42).
Several additional ORFs were identified within the CRDI
with the potential to act as virulence factors. The ORF
ECs1236 of CRDI 69c encodes a putative outer membrane
precursor protein with a Pfam06316:Ail_Lom domain (30).
Proteins with this domain include the Ail protein of Yersinia
enterocolitica, which contributes to invasion of cultured cell
lines (35), and the Lom bacteriophage protein, which has been
shown to confer serum resistance (3). E. coli O157:H7, how-
ever, is not invasive, and so the role of this invasin-like protein
is unclear. The amino terminus of ORF ECs1391 of CRDI 72
displayed high sequence homology to the bundle-forming pilus
(BfpM) protein of EPEC (55). This gene is not required for
formation of bundle-forming pili in EPEC and no other bfp
homologues exist in the E. coli O157:H7 genome, and so it is
difficult to postulate what its role might be (55). The ECs5250
of CRDI 286 was shown to be required for colonization of
calves (9), but its function is unknown. The CRDI pO157-RT
includes a putative reverse transcriptase on the pO157 viru-
lence plasmid of E. coli O157:H7 (7, 29), but the function of
the putative reverse transcriptase in E. coli O157:H7 is also
unknown. Lastly, several hypothetical protein genes were also
identified on prophage or prophage-like element-associated
CRDI. Again, the effects of these genes on bacterial virulence,
if any, are unknown.
The paucity of human clinical isolates within E. coli
O157:H7 LSPA-6 genotype 222222 and some subsets of OBGS
lineage II suggests but does not prove that these strains lack
virulence factors present in other E. coli O157:H7 lineages (22,
63). The identification of potential virulence factors in LSPA-6
111111 strains that are lacking in LSPA-6 222222 strains sup-
ports this hypothesis, but there is no direct evidence that these
regions are involved in pathogenicity. Further functional and
epidemiological analyses of genes within the CRDI are essen-
tial to elucidate the impact that genome evolution has had on
the virulence characteristics of populations emerging within
the O157:H7 clonal complex.
CRDI support the hypothesis that lineage I may be the
ancestral state of contemporary O157:H7. Based on previous
studies, it has been proposed that lineage I isolates represent
the ancestral state of O157:H7, whereas lineage II isolates are
derived (22, 63). This conclusion was based largely upon find-
ings that several lineage I-specific genome segments or alleles
are shared with K-12 and other E. coli strains (63). Our find-
ings with CRDI are consistent with this hypothesis. As dis-
cussed above, many of the CRDI can be found in other E. coli
strains, including distantly related K-12 and UPEC strains. The
simplest explanation for their absence in lineage II strains is
that they were lost during the divergence of lineage II popu-
lations.
Many of the ORFs associated with the CRDI regions were
found in close proximity to bacteriophage, transposon, and
Rhs element genes. Given the presence of numerous copies of
these elements in E. coli O157:H7 genomes (16, 43), it seems
highly likely that genome evolution occurred rapidly by move-
ment of these elements or by recombination events occurring
within or near these elements. Genomic diversity in human
strains of E. coli Sakai was previously shown by comparative
genomic hybridization and whole-genome PCR scanning to
be strongly associated with the presence of bacteriophage
(37, 38).
In a recent publication by Wick et al. (62), a microarray was
used to study the conservation of E. coli O157:H7 genes in
strains representing intermediates in the proposed evolution of
E. coli O157:H7 and E. coli O55:H7. The microarray results
indicated that the majority of the ORFs identified in this study
within CRDI 16, 69a, 69b, 69c, 72, 78, 91/92/93, 153, and 286
were acquired recently by E. coli O157:H7 SOR GUD
strains. All of these CRDI were located on bacteriophage,
suggesting that these differences were a result of bacteriophage
excision or recombination.
In conclusion, several CRDI that are conserved in LSPA-6
genotype 111111 strains but are not found in genotype 222222
strains were identified, supporting the existence of two
genomic lineages of E. coli O157:H7 strains. These CRDI
contain a number of potential virulence factors, including a
putative hemolysin activation protein, a possible iron transport
system, and several regulatory genes. These potential virulence
factors warrant further study to determine their contribution to
the pathogenicity of E. coli O157:H7 strains.
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